L.‐C. Chu
Impact in
- Physiology top 5%
- Nitric Oxide and Endothelin Effects
- Adenosine and Purinergic Signaling
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 4
-
- Forensic Toxicology and Drug Analysis 2
- Co-authors
- Thomas P. Zimmerman (5 shared papers)P Imhof (4 shared papers)Gerald Wolberg (1 shared paper)Juerg Hodler (2 shared papers)William F. Bayne (4 shared papers)Felix E. Burkart (1 shared paper)A. Gérardin (1 shared paper)Philipp Müller (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (4 papers)European Journal of Clinical Pharmacology (3 papers)Biochemical Pharmacology (2 papers)Analytical Biochemistry (1 paper)Science (1 paper)
- Partner nations
- SwitzerlandGermanyUnited Kingdom
In The Last Decade
L.‐C. Chu
16 papers receiving 565 citations
Peers
Comparison fields: 5 of 67
- Physiology 98
- Pharmaceutical Science 89
- Cardiology and Cardiovascular Medicine 145
- Pharmacology 56
- Physiology 142
Countries citing papers authored by L.‐C. Chu
This map shows the geographic impact of L.‐C. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.‐C. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.‐C. Chu more than expected).
Fields of papers citing papers by L.‐C. Chu
This network shows the impact of papers produced by L.‐C. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.‐C. Chu. The network helps show where L.‐C. Chu may publish in the future.
Co-authors
The 14 scholars most cited alongside L.‐C. Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1975 | 246 | |
| 2 | 1980 | 128 | |
| 3 | 1982 | 112 | |
| 4 | 1982 | 41 | |
| 5 | Identification of 6-methylmercaptopurine ribonucleoside 5'-diphosphate and 5'-triphosphate as metabolites of 6-mercaptopurine in man. | 1974 | 37 |
| 6 | 1979 | 23 | |
| 7 | 1976 | 22 | |
| 8 | 1979 | 22 | |
| 9 | 1974 | 21 | |
| 10 | 1981 | 21 | |
| 11 | 1976 | 20 | |
| 12 | 1981 | 10 | |
| 13 | 1974 | 7 | |
| 14 | 1984 | 7 | |
| 15 | 1984 | 6 | |
| 16 | 1985 | 2 |
About L.‐C. Chu
L.‐C. Chu is a scholar working on Pharmaceutical Science, Toxicology, Cardiology and Cardiovascular Medicine, Molecular Biology and Analytical Chemistry, having authored 16 papers that have together received 725 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (4 papers), Biochemical and Molecular Research (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Analytical Methods in Pharmaceuticals (2 papers), Cardiovascular Health and Disease Prevention (2 papers), Blood Pressure and Hypertension Studies (2 papers), Forensic Toxicology and Drug Analysis (2 papers) and Enzyme function and inhibition (2 papers). The work is most often cited by research in Physiology (98 citations), Pharmaceutical Science (89 citations), Cardiology and Cardiovascular Medicine (145 citations), Pharmacology (56 citations) and Physiology (142 citations). L.‐C. Chu has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include Thomas P. Zimmerman, P Imhof, Gerald Wolberg, Juerg Hodler, William F. Bayne, Felix E. Burkart, A. Gérardin, Philipp Müller, Felix Theeuwes and Gertrude B. Elion. Their work appears in journals such as Journal of Pharmaceutical Sciences, European Journal of Clinical Pharmacology, Biochemical Pharmacology, Analytical Biochemistry and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.